Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.

Gynecologic oncology - 1 Mar 2013

Li Yan, Hao Ya-li, Kang Shan, Zhou Rong-miao, Wang Na, Qi Bing-li

Abstract excerpt

AIM: In this study, we evaluated whether functional polymorphisms within the Fas and FasL genes were associated with the risk of developing epithelial ovarian cancer (EOC) and survival of patients with EOC. METHODS: A case-control study was performed in 342 EOC patients and 344 control women. The genotypes of three promoter region polymorphisms (Fas -1377G/A, -670A/G and FasL -844T/C) were determined using ligase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to Fas Ligand Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Prognosis

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 23234803
DOI: 10.1016/j.ygyno.2012.12.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.PMID 23234803Read ↗

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.Semantic proximity Read ↗

Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.Semantic proximity Read ↗

The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.Semantic proximity Read ↗

The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.Semantic proximity Read ↗

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.Semantic proximity Read ↗

Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.Semantic proximity Read ↗

Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.Semantic proximity Read ↗

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Semantic proximity Read ↗

Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.Semantic proximity Read ↗

FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.Semantic proximity Read ↗

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.Semantic proximity Read ↗

Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.